Cardiff Oncology, Inc. - Common Stock (CRDF)
Seasonality Analysis
Cardiff Oncology, Inc. - Common Stock Annual Seasonality Statistics
Cardiff Oncology, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January WORST | -5.19% | Very Weak | |
| February | -0.37% | Weak | |
| March | -2.57% | Very Weak | |
| April | -3.41% | Very Weak | |
| May | 0.87% | Weak | |
| June | 2.29% | Weak | |
| July BEST | 7.94% | Weak | |
| August | 6.70% | Weak | |
| September | 0.38% | Weak | |
| October | 1.80% | Weak | |
| November | 2.86% | Weak | |
| December | 5.27% | Weak |
Cardiff Oncology, Inc. - Common Stock 2026 vs Historical Pattern
Cardiff Oncology, Inc. - Common Stock Interactive Seasonality Chart
Cardiff Oncology, Inc. - Common Stock Pattern Scanner
Cardiff Oncology, Inc. - Common Stock Seasonal Historical Performance
About Cardiff Oncology, Inc. - Common Stock (CRDF) Seasonality
Cardiff Oncology, Inc. - Common Stock (CRDF) has been analyzed using 22 years of historical data to identify seasonal patterns. Classified under Stocks, Cardiff Oncology, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Cardiff Oncology, Inc. - Common Stock is historically July, with an average return of 7.94% and a win rate of 32%. Conversely, January tends to be the weakest month, averaging -5.19% return.
Looking at the full calendar year, Cardiff Oncology, Inc. - Common Stock has an average annual return of 16.55% with an overall monthly win rate of 39.3%. Out of 12 months, 8 typically show positive average returns.
The seasonal pattern for Cardiff Oncology, Inc. - Common Stock has a consistency score of 38.8 (Poor), based on 23 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Cardiff Oncology, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Cardiff Oncology, Inc. - Common Stock (CRDF)?
Historically, July has been the best month for Cardiff Oncology, Inc. - Common Stock, with an average return of 7.94% and a win rate of 32%. However, past performance does not guarantee future results.
What is the worst month for Cardiff Oncology, Inc. - Common Stock (CRDF)?
Based on historical data, January has been the weakest month for Cardiff Oncology, Inc. - Common Stock, with an average return of -5.19%. This is a historical observation and does not guarantee future results.
How reliable is CRDF seasonality data?
The seasonality analysis for Cardiff Oncology, Inc. - Common Stock is based on 22 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Cardiff Oncology, Inc. - Common Stock seasonality in my trading?
Use Cardiff Oncology, Inc. - Common Stock (CRDF) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.